Dr. PAWAN KUMAR RAGHAV
Also known as: Computational Immunologist, Executable Biologist
UCSF, UCSF Medical Center, National Institute of Cancer Prevention and Research
About
Dr. Pawan Kumar Raghav, Ph.D., PGDCI, M. Phil., M.Sc., B.Sc., is a distinguished scientist with over a decade of experience who has significantly contributed to research in stem cells and computational biology. Dr. Raghav received his Ph.D. in life sciences from Bharathiar University, Coimbatore, India. During his Ph.D. at the Institute of Nuclear Medicine and Allied Sciences (INMAS), Defense Research Development Organization (DRDO), Delhi, India, he delved into designing and evaluating molecules with applications in stem cell regulation, focusing on proliferation, differentiation, and apoptosis. As a research associate at INMAS, DRDO, he contributed to hematopoietic stem cell research, formulated peptides-PLGA nanoparticles, and validated their efficacy in in vitro and in vivo studies. Dr. Pawan Kumar Raghav is the recipient of a National Postdoctoral Fellowship from the Department of Science and Technology (DST), SERB, Government of India. As a principal investigator of the project at the Department of Computational Biology, IIIT Delhi, India, he worked on machine learning algorithms and databases. As a Scientist 'D' in the Stem Cell Facility, AIIMS, Delhi, India, Dr. Pawan Kumar Raghav carried out stem cell informatics and tissue engineering experimental studies to generate clinical-grade mesenchymal stem cells (MSCs). Dr. Raghav's career has centered on experimental and computational biology, with research spanning stem cells, immunology, cheminformatics, structural biology, tissue engineering, and molecular biology. Dr. Raghav's contributions are evident through numerous publications in prestigious scientific journals, book chapters, books, and patents that provide insight into stem cells and immunology. He also serves as an editor and reviewer for international journals and books. Dr. Pawan Kumar Raghav's remarkable contributions have earned him recognition, including travel, research excellence, and best research awards. He is a member of the American Society for Histocompatibility and Immunogenetics (ASHI) and the International Society for Computational Biology (ISCB). Currently, he is working at UCSF, San Francisco, California, USA on HLA-based studies for bone marrow and solid organ transplantation.
Employment
-
UCSF Associate Specialist2025 - Present
-
UCSF Medical Center Research Employee2021 - 2025
-
National Institute of Cancer Prevention and Research Project Coordinator2020 - 2020
-
All India Institute of Medical Sciences Scientist D2019 - 2020
-
Indraprastha Institute of Information Technology Delhi Postdoctoral Fellow2017 - 2019
-
DRDO Institute of Nuclear Medicine and Allied Sciences Research Associate2016 - 2017
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (55)
- Population-Agnostic Real-Time Molecular Mismatch Estimation Using rSSO-Defined HLA Allele Strings: Minimal Impact of Allelic Discordance With NGS Save
- Expanded Allelic Diversity of Non‐Classical HLA Class I and MIC Loci Identified Using Full‐Gene Hybrid Capture‐Based Next‐Generation Sequencing Save
- Non-HLA antibody trajectories may predict kidney transplant outcomes Save
- Unlocking hematopoietic stem cell potential: integrative computational approaches for genomic and transcriptomic analysis Save
- Editorial: Advancements in hematopoietic stem cell proliferation and self-renewal maintenance Save
- Editorial: Improving stem cell transplantation delivery using computational modelling Save
- Nano-Delivery Revolution: Harnessing Mesenchymal Stem Cell-Derived Exosomes’ Potential for Wound Healing Save
- COVID-19 diagnostic approaches and modern mesenchymal stem cell-based treatment Save
- Clinical investigation of COVID-19 prevention and treatment Save
- Comparative clinical investigation of blood profiling in COVID-19 patients Save